Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Lakshmi Life Sciences Ltd21-03-2017
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Lakshmi Life Sciences LtdDisclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Lakshmi Life Sciences LtdStandalone Financial Results, Limited Review Report for December 31, 2016
Super Sales India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 2016Change in Designation
Super Sales India Ltd has informed BSE that Sri N R Selvaraj who has appointed as Wholetime director of the Company and his term expired on January 31, 2017. At the 34th Annual General Meeting held on August 01, 2016, shareholders have appointed him as Managing Director of the Company for a period of three years with effect from February 01, 2017.Closure of Trading Window
Super Sales India Ltd has informed BSE that a meeting of Board of Directors of the Company is scheduled to be held on February 06, 2017, inter alia, to consider unaudited financial results for the quarter ended December 31, 2016.In view of the code of conduct adopted by the Board of Directors of the Company read with SEBI (Prohibition of Insider Trading) Regulation 2015, the period from January 25, 2017 to February 08, 2017, both days inclusive,...Board Meeting Intimation for Results
Super Sales India Ltd has informed BSE that a meeting of Board of Directors of the Company is being convened to be held on February 06, 2017, interalia, to consider the unaudited financial results of the Company for the quarter ended December 31, 2016.Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Super Sales India Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Shareholding for the Period Ended December 31, 2016
Super Sales India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click hereUpdates
Super Sales India Ltd has submitted to BSE a copy of the advertisement published in the newspapers dated December 01, 2016 titles - Notice (for transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF) Suspense Account).Standalone Financial Results, Limited Review Report for September 30, 2016
Super Sales India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 2016